17:27 EDT Capricor Therapeutics (CAPR) files $300M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor Therapeutics responds to FDA posting of dermiocel CRL
- CAPR Lawsuit Alert! Class Action Lawsuit Against Capricor Therapeutics
- Capricor Therapeutics Faces Challenges Despite Strong Cash Position
- Capricor Therapeutics: Promising Developments in Exosome-Based Vaccine and Strategic Engagements with FDA
- Capricor announces first subjects dosed in Phase 1 trial of StealthX